Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NEO Battery Materials Appoints Kenneth Hoffman, Distinguished Battery Industry Leader and Former McKinsey’s Global Head of Battery Materials, as New Director
-
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
-
Reducto Raises $24.5M Series A Round to Help Enterprises Unlock Unstructured Data
-
Pacific Financial Corp Earns $2.4 Million, or $0.24 per Diluted Share for First Quarter 2025; Board of Directors Approves 5% Stock Buyback Plan; Declares Quarterly Cash Dividend of $0.14 per Share
-
Preferred Bank Reports First Quarter Results
-
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
-
Paddle Finance Announce launch on Berachain: Liquidity Tools for Assets Most Protocols Ignore
-
TGI Fridays Appoints Phil Broad as President of International Franchising
-
BTS Group’s Annual Report 2024 is now available online
-
Nexxen to Host Inaugural Investor Day on May 22, 2025
-
Swiss Properties Invest A/S: Results of the Annual General Meeting
-
Telos Corporation to Announce First Quarter 2025 Financial Results on May 9, 2025
-
Porsche celebrates fifty years since the original audacious adventure
-
Huhtamäki Oyj - Managers' Transactions (Vauramo)
-
CERo Therapeutics Holdings, Inc. to Present Poster on Lead Program, CER-1236, at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
-
Harju County Court made an interim judgement regarding the claim filed by Tallinn University of Technology against Tallinna Vesi
-
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
-
StepStone Group Closes Fourth Tactical Growth Fund with Over $700 Million in Capital Commitments
-
MIXXERS Premium Portable Cocktail Packets for Outdoor Enthusiasts
-
Harbourfront Wealth Acquires KJ Harrison & Partners, a $2.2 billion CIRO dealer
-
TopBuild Achieves 2025 Great Place to Work Certification for Third Consecutive Year
-
Best Gold IRA Companies of 2025 Announced
-
Silicon Motion Confirms Quarterly Dividend
-
LGI Homes Opens New Section at Popular Second Creek Farm Community in Commerce City, CO
-
Enviri Corporation to Participate in Upcoming Investor Conferences
-
Oxbridge / SurancePlus to Attend TOKEN2049 Dubai
-
Genius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025
-
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
-
Access Meets Impact at NJIT, Recognized by Carnegie Classifications
-
VYNE Therapeutics Provides Update on VYN202 Program
-
Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025
-
Greif Honored as Stevie® Award Winner in 2025 American Business Awards®
-
North American Construction Group Ltd. Announces Pricing of Private Placement Offering of $225 Million Senior Unsecured Notes
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended March 31, 2025 and Declaration of Distributions on Common Stock for the Months Ending July 31
-
Gentex Reports First Quarter 2025 Financial Results
-
Spiritual Essay Collection THE WALK Inspires Christians to Seek Opportunities to Be Kind
-
Guardforce AI to Host Year-End 2024 Financial Results Conference Call on Monday, April 28th at 8:30 A.M. ET
-
Esperion to Participate in The Citizens Life Sciences Conference
-
Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Quantum Computing Inc. and Certain Officers – QUBT
-
Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
-
BetterAlt and The Vitamin Shoppe Forge Partnership to Broaden Premium Wellness Selection
-
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
-
Managers’ transactions
-
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
-
BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes
-
Ponce Financial Group, Inc. Reports First Quarter 2025 Results
-
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
-
Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
-
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

